Evidence map›Paper›PMID 31127873›Full record

ArticleCancer science2019

Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.

Rudy Xie, Yukari Okita, Yumu Ichikawa, Muhammad Ali Fikry, Kim Tuyen Huynh Dam, Sophie Thi PhuongDung Tran, Mitsuyasu Kato

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Glycoprotein nonmetastatic melanoma protein B: A key mediator and an emerging therapeutic target in autoimmune diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rudy XieDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yukari OkitaDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID https://orcid.org/0000-0002-7279-4634
Yumu IchikawaDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Muhammad Ali FikryDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Kim Tuyen Huynh DamDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Sophie Thi PhuongDung TranDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Mitsuyasu KatoDepartment of Experimental Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.ORCID https://orcid.org/0000-0001-9905-2473
University of Tsukuba · JP

Funding

Japan Society for the Promotion of Science JP15K29070Japan Society for the Promotion of Science JP17K14981Japan Society for the Promotion of Science JP18H02676Uehara Memorial Foundation
6 · The paper itself

Abstract

Glycoprotein NMB (GPNMB) is highly expressed in many types of malignant tumors and thought to be a poor prognostic factor in those cancers, including breast cancer. Glycoprotein NMB is a type IA transmembrane protein that has a long extracellular domain (ECD) and a short intracellular domain (ICD). In general, the ECD of a protein is involved in protein-protein or protein-carbohydrate interactions, whereas the ICD is important for intracellular signaling. We previously reported that GPNMB contributes to the initiation and malignant progression of breast cancer through the hemi-immunoreceptor tyrosine-based activation motif (hemITAM) in its ICD. Furthermore, we showed that the tyrosine residue in hemITAM is involved in induction of the stem-like properties of breast cancer cells. However, the contribution of the ECD to its tumorigenic function has yet to be fully elucidated. In this study, we focused on the region, the so-called kringle-like domain (KLD), that is conserved among species, and made a deletion mutant, GPNMB(ΔKLD). Enhanced expression of WT GPNMB induced sphere and tumor formation in breast epithelial cells; in contrast, GPNMB(ΔKLD) lacked these activities without affecting its molecular properties, such as subcellular localization, Src-induced tyrosine phosphorylation at least in overexpression experiments, and homo-oligomerization. Additionally, GPNMB(ΔKLD) lost its cell migration promoting activity, even though it reduced E-cadherin expression. Although the interaction partner binding to KLD has not yet been identified, we found that the KLD of GPNMB plays an important role in its tumorigenic potential.

Indexed as

MutationAmino Acid SequenceAnimalsAntigens, CDBreast NeoplasmsCadherinsCell Line, TumorCell MovementConserved SequenceFemaleGene Expression Regulation, NeoplasticHumansKringlesMembrane GlycoproteinsMiceNeoplasm TransplantationAntigens, CDCadherinsCDH1 protein, humanGPNMB protein, humanMembrane Glycoproteinsepithelial-mesenchymal transitionGPNMBkringle-like domainsphere formationtumorigenicity

Identifiers

PMID31127873
PMCPMC6609797
OpenAlexW2946405097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.